2026 June 17 | Business Today Qatar

You are here: Home » 2026 » June » Archives for 17th

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WGS

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”), of the important August 3, 2026 lead plaintiff deadline.

SO WHAT: If you purchased GeneDx common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the GeneDx class action, go to https://www.rosenlegal.com/cases/genedx-holdings-corp/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 3, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the claims against defendants arise from their misrepresentations and omissions regarding GeneDx’s statements regarding the impact of Fabric on the overall business of GeneDx. Throughout the Class Period, GeneDx repeatedly made statements that would have caused the average investor to believe that the Fabric acquisition would improve GeneDx’s financials and create efficiencies between it and GeneDx’s core business. These statements include such statements such as: “There is room to run in terms of reducing COGS in the future by combining the best of capability between GeneDx and Fabric as we lean into the best possible algorithms to optimize dry lab processes.” These and similar statements made throughout the Class Period were false. In truth, defendants knew of, or recklessly disregarded, significant problems in Fabric’s viability that would negatively impact GeneDx’s overall business and operations. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the GeneDx class action, go to https://www.rosenlegal.com/cases/genedx-holdings-corp/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

GLOBENEWSWIRE (Distribution ID 9748897)

ROSEN, THE FIRST FILING FIRM, Encourages Zillow Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – Z, ZG

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of Class A or Class C common stock of Zillow Group, Inc. (NASDAQ: ZG) (NASDAQ: Z) between February 11, 2025 and May 7, 2026, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026 in the securities class action first filed by the Firm.

SO WHAT: If you purchased Zillow common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Zillow class action, go to https://rosenlegal.com/cases/zillow-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Zillow's agreement with Redfin Corporation was not a “partnership,” but rather an acquisition of Redfin's business; (2) as a result of the Redfin Agreement, Zillow faced a materially heightened risk of regulatory scrutiny and liability under federal antitrust laws; (3) upon the filing of an antitrust lawsuit, Zillow continued to downplay its legal exposure; and (4) as a result, defendants' statements about Zillow's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Zillow class action, go to https://rosenlegal.com/cases/zillow-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40^th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GLOBENEWSWIRE (Distribution ID 9748901)

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Via Transportation, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VIA

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Via Transportation, Inc. (NYSE: VIA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with Via's initial public offering (the “IPO” or “Offering”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026.

SO WHAT: If you purchased Via common stock pursuant and/or traceable to the IPO you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Via class action, go to https://rosenlegal.com/cases/via-transportation-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the complaint, the Offering Documents used to effectuate Via's IPO were false and misleading and omitted to state that, at the time of the IPO, Via's growth had already begun to encounter obstacles because of Via's declining Platform Annual Run-Rate Revenue and inability to grow in Germany. As these facts emerged after the IPO, Via shares fell sharply. By the commencement of this action, Via's shares traded as low as $14.52, a decline of nearly 70% from the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Via class action, go to https://rosenlegal.com/cases/via-transportation-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

GLOBENEWSWIRE (Distribution ID 9748877)

Publication relating to transparency notifications

REGULATED INFORMATION

Publication relating to transparency notifications

Mont-Saint-Guibert (Belgium), June 17, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received transparency notifications as detailed below.

Robert Taub

On June 16, 2026, Nyxoah received a transparency notification from Robert Taub following an acquisition of voting securities by Robert Taub and Robelga SRL (an entity controlled by Robert Taub). Based on the notification, on June 10, 2026, Robert Taub (together with Robelga SRL) held 14,440,277 voting rights, representing 14.45% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284), and 50,000 equivalent financial instruments, representing 0.05% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 16, 2026 contains the following information:

Reason for the notification: acquisition or disposal of voting securities or voting rights
Notification by: a parent undertaking or a controlling person
Persons subject to the notification requirement:
- Robert Taub
- Robelga SRL (with address at Avenue des Croix de Guerre 149 / 13, 1120 Brussels)
Date on which the threshold was crossed: June 10, 2026
Threshold that is crossed: 10%
Denominator: 99,926,284
Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Robert Taub	2,712,510	6,766,564		6.77%
Robelga SRL	1,598,290	7,673,713		7.68%
Subtotal	4,310,800	14,440,277		14.45%
	TOTAL	14,440,277	0	14.45%	0.00%

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
Robert Taub	Warrants	08/06/2027		25,000	0.03%	cash
Robert Taub	Warrants	14/06/2028		25,000	0.03%	cash
	TOTAL			50,000	0.05%

	TOTAL (A & B)			# of voting rights	% of voting rights
				14,490,277	14.50%

Full chain of controlled undertakings through which the holding is effectively held: Robelga SRL is 100% owned by BMI Estate (a partnership (société simple) without legal personality). Robert Taub has 100% usufruct and Robert Taub’s children have 100% bare ownership of BMI Estate.

Pierre-Edouard Stérin

On June 17, 2026, Nyxoah received a transparency notification from Pierre-Edouard Stérin following an acquisition of voting securities by B.A.D. 21 SRL (an entity controlled by Pierre-Edouard Stérin). Based on the notification, on June 10, 2026, Pierre-Edouard Stérin (taking into account the holdings of his affiliates) held 7,221,666 voting rights, representing 7.23% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 17, 2026 contains the following information:

Reason for the notification: acquisition or disposal of voting securities or voting rights
Notification by: a parent undertaking or a controlling person
Persons subject to the notification requirement:
- Pierre-Edouard Stérin
- Lemahieu Holding SRL (with address at Rue Haute 21, 1380 Lasne, Belgium)
- Graal Holding SRL (with address at Rue Haute 21, 1380 Lasne, Belgium)
- B.A.D. 21 SRL (with address at Rue Haute 21, 1380 Lasne, Belgium)
Date on which the threshold was crossed: June 10, 2026
Threshold that is crossed: 5%
Denominator: 99,926,284
Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Pierre-Edouard Stérin		0	0	0.00%	0.00%
Lemahieu Holding SRL		0	0	0.00%	0.00%
Graal Holding SRL		0	0	0.00%	0.00%
B.A.D. 21 SRL		7,221,666	0	7.23%	0.00%
Subtotal		7,221,666		7.23%
	TOTAL	7,221,666	0	7.23%	0.00%

Full chain of controlled undertakings through which the holding is effectively held: B.A.D. 21 SRL is controlled by Graal Holding SRL, which itself is controlled by Lemahieu Holding SRL, which is controlled by Mr. Pierre-Edouard Stérin.

Cochlear Limited

On June 16, 2026, Nyxoah received a transparency notification from Cochlear Limited following the passive crossing of a threshold by Cochlear Investments Pty Ltd (an entity controlled by Cochlear Limited). Based on the notification, on June 10, 2026, Cochlear Limited (taking into account the holding of its affiliate) held 5,847,283 voting rights, representing 5.85% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 15, 2026 contains the following information:

Reason for the notification: passive crossing of a threshold
Notification by: a parent undertaking or a controlling person
Persons subject to the notification requirement:
- Cochlear Limited (with address at 1 University Avenue, Macquarie University, NSW 2109, Australia)
- Cochlear Investments Pty Ltd (with address at 1 University Avenue, Macquarie University, NSW 2109, Australia)
Date on which the threshold was crossed: June 10, 2026
Threshold that is crossed: 10%
Denominator: 99,926,284
Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Cochlear Limited	0	0	0	0.00%	0.00%
Cochlear Investments Pty Ltd	5,631,319	5,847,283	0	5.85%	0.00%
Subtotal	5,631,319	5,847,283		5.85%
	TOTAL	5,847,283	0	5.85%	0.00%

Full chain of controlled undertakings through which the holding is effectively held: Cochlear Investments Pty Ltd is a wholly owned subsidiary of Cochlear Limited, which is listed on the Australian Securities Exchange and has no controlling shareholder.
Additional information: Cochlear Investments Pty Ltd acquired 215,964 ordinary shares in Nyxoah pursuant to a private placement completed on November 18, 2025, resulting in an increase of its shareholding to 5,847,283 ordinary shares which did not trigger any crossing of a threshold.

This notification concerns a downwards crossing of the 10% threshold following a passive decrease, whereby Cochlear Investments Pty Ltd’s holding in Nyxoah fell from 14.999% (as previously notified in September 2025) and 13.08% immediately prior to the capital increase, to 5.85% of the voting rights.
We understand the underwriters have been granted a 30-day option to subscribe for up to an additional 8,284,883 ordinary shares, which could further reduce Cochlear's holding to 5.40% without crossing any additional disclosure threshold.

Gilde Healthcare Holding B.V.

On June 16, 2026, Nyxoah received a transparency notification from Gilde Healthcare Holding B.V. following the passive downward crossing of the lowest threshold.

The notification dated June 15, 2026 contains the following information:

Reasons for the notification:
- Passive crossing of a threshold
- Downward crossing of the lowest threshold
Notification by: a parent undertaking or a controlling person
Persons subject to the notification requirement:
- Gilde Healthcare Holding B.V. (with address at Stadsplateau 36, 3521 AZ Utrecht, the Netherlands)
- Gilde Healthcare III Management B.V. (with address at Stadsplateau 36, 3521 AZ Utrecht, the Netherlands)
Date on which the threshold was crossed: June 10, 2026
Threshold that is crossed: 3%
Denominator: 99,926,284
Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Gilde Healthcare Holding B.V.
Gilde Healthcare III Management B.V.
	TOTAL

Full chain of controlled undertakings through which the holding is effectively held: Gilde Healthcare III Management B.V. is controlled by Gilde Healthcare Holding B.V. Gilde Healthcare Holding B.V. is not a controlled entity.
Additional information: Cooperatieve Gilde Healthcare III Sub-Holding UA and Cooperatieve Gilde Healthcare III Sub-Holding 2 UA hold the shares in Nyxoah. Gilde Healthcare III Management B.V. is the management company of these two entities, that in the absence of specific instructions can exercise the voting rights at its discretion.

Bank of America Corporation

On June 15, 2026, Nyxoah received a transparency notification from Bank of America Corporation following an acquisition of voting securities and of financial instruments that are treated as voting securities by entities that are controlled by Bank of America Corporation. Based on the notification, on June 10, 2026, Bank of America Corporation (taking into account the holdings of its affiliates) held 449,288 voting rights, representing 0.45% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284), and 2,971,370 equivalent financial instruments, representing 2.97% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 12, 2026 contains the following information:

Reason for the notification:
- Acquisition or disposal of voting securities or voting rights
- Acquisition or disposal of financial instruments that are treated as voting securities
Notification by: a parent undertaking or a controlling person
Persons subject to the notification requirement:
- Bank of America Corporation (with address at 1209 Orange Street – Corporation Trust Center, Wilmington DE 19801, United States of America)
Date on which the threshold was crossed: June 10, 2026
Threshold that is crossed: 3%
Denominator: 99,926,284
Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Bank of America Corporation		0		0.00%
Bank of America, National Association		7,319		0.01%
BofA Securities, Inc.		393,157		0.39%
Merrill Lynch International		48,812		0.05%
Subtotal		449,288		0.45%
	TOTAL	449,288	0	0.45%	0.00%

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
Merrill Lynch International	Right to recall			15,001	0.02%	physical
Merrill Lynch International	Rights of use			1	0.00%	physical
BofA Securities, Inc.	Rights of use			1,873,387	1.87%	physical
BofA Securities, Inc.	Right to recall			1,080,480	1.08%	physical
Bank of America, NA	Swap	15/10/2027		991	0.00%	cash
Merrill Lynch International	Swap	15/02/2028		519	0.00%	cash
Merrill Lynch International	Swap	15/10/2027		991	0.00%	cash
	TOTAL			2,971,370	2.97%

	TOTAL (A & B)			# of voting rights	% of voting rights
				3,420,658	3.42%

Full chain of controlled undertakings through which the holding is effectively held: Bank of America, National Association, BofA Securities, Inc. and Merrill Lynch International are controlled by Bank of America Corporation. Bank of America Corporation is not a controlled entity.

Bank of America Corporation

On June 15, 2026, Nyxoah received a transparency notification from Bank of America Corporation following the disposal of voting securities and of financial instruments that are treated as voting securities by entities that are controlled by Bank of America Corporation resulting in the downward crossing of the lowest threshold. Based on the notification, on June 10, 2026, Bank of America Corporation (taking into account the holdings of its affiliates) held 269,166 voting rights, representing 0.27% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284), and 2,551,461 equivalent financial instruments, representing 2.55% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 15, 2026 contains the following information:

Reason for the notification:
- Downward crossing of the lowest threshold
- Acquisition or disposal of voting securities or voting rights
- Acquisition or disposal of financial instruments that are treated as voting securities
Notification by: a parent undertaking or a controlling person
Persons subject to the notification requirement:
- Bank of America Corporation (with address at 1209 Orange Street – Corporation Trust Center, Wilmington DE 19801, United States of America)
Date on which the threshold was crossed: June 11, 2026
Threshold that is crossed: 3%
Denominator: 99,926,284
Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Bank of America Corporation	0	0		0.00%
Bank of America, National Association	7,319	7,319		0.01%
BofA Securities, Inc.	393,157	216,277		0.22%
Merrill Lynch International	48,812	45,570		0.05%
Subtotal	449,288	269,166		0.27%
	TOTAL	269,166	0	0.27%	0.00%

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
Merrill Lynch International	Right to recall			15,000	0.02%	physical
BofA Securities, Inc.	Rights of use			1,445,424	1.45%	physical
BofA Securities, Inc.	Right to recall			1,088,536	1.09%	physical
Bank of America, NA	Swap	15/10/2027		991	0.00%	cash
Merrill Lynch International	Swap	15/02/2028		519	0.00%	cash
Merrill Lynch International	Swap	15/10/2027		991	0.00%	cash
	TOTAL			2,551,461	2.55%

	TOTAL (A & B)			# of voting rights	% of voting rights
				2,820,627	2.82%

Full chain of controlled undertakings through which the holding is effectively held: Bank of America, National Association, BofA Securities, Inc. and Merrill Lynch International are controlled by Bank of America Corporation. Bank of America Corporation is not a controlled entity.

* *

Contact:
Nyxoah
John Landry, CFO
[email protected]

Attachment

2026 06 17 PR Transparency notification (Robelga BAD21 Cochlear Gilde BofA) (ENG)

GLOBENEWSWIRE (Distribution ID 1001188347)

Publication relative à des notifications de transparence

INFORMATION RÉGLEMENTÉE

Publication relative à des notifications de transparence

Mont-Saint-Guibert (Belgique), le 17 juin 2026, 22:30h CET / 17:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA (Euronext Brussels/Nasdaq : NYXH) annonce qu’elle a reçu des notifications de transparence comme détaillées ci-dessous.

Robert Taub

Le 16 juin 2026, Nyxoah a reçu une notification de transparence de Robert Taub à la suite d’une acquisition de titres conférant le droit de vote par Robert Taub et Robelga SLR (une entité contrôlée par Robert Taub). Sur la base de la notification, le 10 juin 2026, Robert Taub (avec Robelga SRL) détenait 14.440.277 droits de vote, représentant 14,45 % du nombre total des actions émises par Nyxoah au 10 juin 2026 (99.926.284), et 50.000 instruments financiers assimilés, représentant 0,05 % du nombre total des actions émises par Nyxoah au 10 juin 2026 (99.926.284).

La notification datée du 16 juin 2026 contient les informations suivantes :

Motif de la notification : acquisition ou cession de titres conférant le droit de vote ou de droits de vote
Notification par : une entreprise mère ou une personne détenant le contrôle
Personnes tenues à la notification :
- Robert Taub
- Robelga SRL (avec adresse à Avenue des Croix de Guerre 149 / 13, 1120 Brussels)
Date du dépassement de seuil : le 10 juin 2026
Seuil franchi : 10 %
Dénominateur : 99.926.284
Détails de la notification :

A) Droits de vote	Notification précédente	Après la transaction
	# droits de vote	# droits de vote		% de droits de vote
Détenteurs de droits de vote		Attachés à des titres	Non liés à des titres	Attachés à des titres	Non liés à des titres
Robert Taub	2.712.510	6.766.564		6,77 %
Robelga SRL	1.598.290	7.673.713		7,68 %
Sous-total	4.310.800	14.440.277		14,45 %
	TOTAL	14.440.277	0	14,45 %	0,00 %

B) Instruments financiers assimilés	Après la transaction
Détenteurs d’instruments financiers assimilés	Type d’instrument financier	Date d’échéance	Date ou délai d’exercice ou de conversion	# droits de vote pouvant être acquis en cas d’exercice de l’instrument	% de droits de vote	Règlement
Robert Taub	Droits de souscription	08/06/2027		25.000	0,03 %	en espèces
Robert Taub	Droits de souscription	14/06/2028		25.000	0,03 %	en espèces
	TOTAL			50.000	0,05 %

	TOTAL (A & B)			# droits de vote	% de droits de vote
				14.490.277	14,50 %

Chaine des entreprises contrôlées par l'intermédiaire desquelles la participation est effectivement détenue : Robelga SRL est 100 % propriété de BMI Estate (société simple sans personnalité juridique). Robert Taub a 100 % l'usufruit et les enfants de Robert Taub ont 100 % la nue-propriété de BMI Estate.

Pierre-Edouard Stérin

Le 17 juin 2026, Nyxoah a reçu une notification de transparence de Pierre-Edouard Stérin à la suite d’une acquisition de titres conférant le droit de vote par B.A.D. 21 SRL (une entité contrôlée par Pierre-Edouard Stérin). Sur la base de la notification, le 10 juin 2026, Pierre-Edouard Stérin (en tenant compte des participations de ses sociétés affiliées) détenait 7.221.666 droits de vote, représentant 7,23 % du nombre total des actions émises par Nyxoah au 10 juin 2026 (99.926.284).

La notification datée du 17 juin 2026 contient les informations suivantes :

Motif de la notification : acquisition ou cession de titres conférant le droit de vote ou de droits de vote
Notification par : une entreprise mère ou une personne détenant le contrôle
Personnes tenues à la notification :
- Pierre-Edouard Stérin
- Lemahieu Holding SRL (avec adresse à Rue Haute 21, 1380 Lasne, Belgique)
- Graal Holding SRL (avec adresse à Rue Haute 21, 1380 Lasne, Belgique)
- B.A.D. 21 SRL (avec adresse à Rue Haute 21, 1380 Lasne, Belgique)
Date du dépassement de seuil : le 10 juin 2026
Seuil franchi : 5 %
Dénominateur : 99.926.284
Détails de la notification :

A) Droits de vote	Notification précédente	Après la transaction
	# droits de vote	# droits de vote		% de droits de vote
Détenteurs de droits de vote		Attachés à des titres	Non liés à des titres	Attachés à des titres	Non liés à des titres
Pierre-Edouard Stérin		0	0	0,00 %	0,00 %
Lemahieu Holding SRL		0	0	0,00 %	0,00 %
Graal Holding SRL		0	0	0,00 %	0,00 %
B.A.D. 21 SRL		7.221.666	0	7,23 %	0,00 %
Sous-total		7.221.666		7,23 %
	TOTAL	7.221.666	0	7,23 %	0,00 %

Chaine des entreprises contrôlées par l'intermédiaire desquelles la participation est effectivement détenue : B.A.D. 21 SRL est contrôlée par Graal Holding SRL, elle-même contrôlée par Lemahieu Holding SRL, laquelle est contrôlée par M. Pierre-Edouard Stérin.

Cochlear Limited

Le 16 juin 2026, Nyxoah a reçu une notification de transparence de Cochlear Limited à la suite du franchissement passif d’un seuil par Cochlear Investments Pty Ltd (une entité contrôlée par Cochlear Limited). Sur la base de la notification, le 10 juin 2026, Cochlear Limited (en tenant compte de la participation de sa société affiliée) détenait 5.847.283 droits de vote, représentant 5,85 % du nombre total des actions émises par Nyxoah au 10 juin 2026 (99.926.284).

La notification datée du 15 juin 2026 contient les informations suivantes :

Motif de la notification : franchissement de seuil passif
Notification par : une entreprise mère ou une personne détenant le contrôle
Personnes tenues à la notification :
- Cochlear Limited (avec adresse à 1 University Avenue, Macquarie University, NSW 2109, Australie)
- Cochlear Investments Pty Ltd (avec adresse à 1 University Avenue, Macquarie University, NSW 2109, Australie)
Date du dépassement de seuil : le 10 juin 2026
Seuil franchi : 10 %
Dénominateur : 99.926.284
Détails de la notification :

A) Droits de vote	Notification précédente	Après la transaction
	# droits de vote	# droits de vote		% de droits de vote
Détenteurs de droits de vote		Attachés à des titres	Non liés à des titres	Attachés à des titres	Non liés à des titres
Cochlear Limited	0	0	0	0,00 %	0,00 %
Cochlear Investments Pty Ltd	5.631.319	5.847.283	0	5,85 %	0,00 %
Sous-total	5.631.319	5.847.283		5,85 %
	TOTAL	5.847.283	0	5,85 %	0,00 %

Chaine des entreprises contrôlées par l'intermédiaire desquelles la participation est effectivement détenue : Cochlear Investments Pty Ltd est une filiale à 100 % de Cochlear Limited, société cotée à l’Australian Securities Exchange et sans actionnaire de contrôle.
Information supplémentaire : Cochlear Investments Pty Ltd a acquis 215.964 actions ordinaires de Nyxoah dans le cadre d’un placement privé réalisé le 18 novembre 2025, portant sa participation à 5.847.283 actions ordinaires. Cette acquisition n’a entraîné aucun franchissement de seuil.

La présente notification concerne un franchissement vers le bas du seuil de 10 % à la suite d’une diminution passive de la participation de Cochlear Investments Pty Ltd dans Nyxoah. Celle-ci est passée de 14,999 % (tel que précédemment notifié en septembre 2025) et de 13,08 % immédiatement avant l’augmentation de capital, à 5,85 % des droits de vote.

À notre connaissance, les souscripteurs se sont vu accorder une option de 30 jours pour souscrire jusqu’à 8.284.883 actions ordinaires supplémentaires, ce qui pourrait réduire davantage la participation de Cochlear Investments Pty Ltd à 5,40 %, sans entraîner de nouveau franchissement d’un seuil de déclaration.

Gilde Healthcare Holding B.V.

Le 16 juin 2026, Nyxoah a reçu une notification de transparence de Gilde Healthcare Holding B.V. à la suite du franchissement passif vers le bas du seuil minimum.

La notification datée du 15 juin 2026 contient les informations suivantes :

Motif de la notification :
- Franchissement de seuil passif
- Franchissement vers le bas du seuil minimum
Notification par : une entreprise mère ou une personne détenant le contrôle
Personnes tenues à la notification :
- Gilde Healthcare Holding B.V. (avec adresse à Stadsplateau 36, 3521 AZ Utrecht, Pays-Bas)
- Gilde Healthcare III Management B.V. (avec adresse à Stadsplateau 36, 3521 AZ Utrecht, Pays-Bas)
Date du dépassement de seuil : le 10 juin 2026
Seuil franchi : 3 %
Dénominateur : 99.926.284
Détails de la notification :

A) Droits de vote	Notification précédente	Après la transaction
	# droits de vote	# droits de vote		% de droits de vote
Détenteurs de droits de vote		Attachés à des titres	Non liés à des titres	Attachés à des titres	Non liés à des titres
Gilde Healthcare Holding B.V.
Gilde Healthcare III Management B.V.
	TOTAL

Chaine des entreprises contrôlées par l'intermédiaire desquelles la participation est effectivement détenue : Gilde Healthcare III Management B.V. est contrôlée par Gilde Healthcare Holding B.V. Gilde Healthcare Holding B.V. n'est pas une entité contrôlée.
Information supplémentaire : Cooperatieve Gilde Healthcare III Sub-Holding UA et Cooperatieve Gilde Healthcare III Sub-Holding 2 UA détiennent les actions de Nyxoah. Gilde Healthcare III Management B.V. est la société de management de ces deux entreprises, qui peut en l'absence d'instructions spécifiques exercer les droits de vote de manière discrétionnaire.

Bank of America Corporation

Le 15 juin 2026, Nyxoah a reçu une notification de transparence de Bank of America Corporation à la suite de l’acquisition, par des entités contrôlées par Bank of America Corporation, de titres conférant le droit de vote et d'instruments financiers assimilés. Sur la base de la notification, le 10 juin 2026, Bank of America Corporation (en tenant compte des participations de ses sociétés affiliées) détenait 449.288 droits de vote, représentant 0,45 % du nombre total des actions émises par Nyxoah au 10 juin 2026 (99.926.284), et 2.971.370 instruments financiers assimilés, représentant 2,97 % du nombre total des actions émises par Nyxoah au 10 juin 2026 (99.926.284).

La notification datée du 12 juin 2026 contient les informations suivantes :

Motif de la notification :
- Acquisition ou cession de titres conférant le droit de vote ou de droits de vote
- Acquisition ou cession d'instruments financiers assimilés
Notification par : une entreprise mère ou une personne détenant le contrôle
Personnes tenues à la notification :
- Bank of America Corporation (avec adresse à 1209 Orange Street – Corporation Trust Center, Wilmington DE 19801, États-Unis)
Date du dépassement de seuil : le 10 juin 2026
Seuil franchi : 3 %
Dénominateur : 99.926.284
Détails de la notification :

A) Droits de vote	Notification précédente	Après la transaction
	# droits de vote	# droits de vote		% de droits de vote
Détenteurs de droits de vote		Attachés à des titres	Non liés à des titres	Attachés à des titres	Non liés à des titres
Bank of America Corporation		0		0,00 %
Bank of America, National Association		7.319		0,01 %
BofA Securities, Inc.		393.157		0,39 %
Merrill Lynch International		48.812		0,05 %
Sous-total		449.288		0,45 %
	TOTAL	449.288	0	0,45 %	0,00 %

B) Instruments financiers assimilés	Après la transaction
Détenteurs d’instruments financiers assimilés	Type d’instrument financier	Date d’échéance	Date ou délai d’exercice ou de conversion	# droits de vote pouvant être acquis en cas d’exercice de l’instrument	% de droits de vote	Règlement
Merrill Lynch International	Right to recall			15.001	0,02 %	physique
Merrill Lynch International	Rights of use			1	0,00 %	physique
BofA Securities, Inc.	Rights of use			1.873.387	1,87 %	physique
BofA Securities, Inc.	Right to recall			1.080.480	1,08 %	physique
Bank of America, NA	Swap	15/10/2027		991	0,00 %	en espèces
Merrill Lynch International	Swap	15/02/2028		519	0,00 %	en espèces
Merrill Lynch International	Swap	15/10/2027		991	0,00 %	en espèces
	TOTAL			2.971.370	2,97 %

	TOTAL (A & B)			# droits de vote	% de droits de vote
				3.420.658	3,42 %

Chaine des entreprises contrôlées par l'intermédiaire desquelles la participation est effectivement détenue : Bank of America, National Association, BofA Securities, Inc. et Merrill Lynch International sont contrôlées par Bank of America Corporation. Bank of America Corporation n'est pas une entité contrôlée.

Bank of America Corporation

Le 15 juin 2026, Nyxoah a reçu une notification de transparence de Bank of America Corporation à la suite de la cession, par des entités contrôlées par Bank of America Corporation, de titres conférant le droit de vote et d'instruments financiers assimilés, entraînant le franchissement vers le bas du seuil minimum. Sur la base de la notification, le 10 juin 2026, Bank of America Corporation (en tenant compte des participations de ses sociétés affiliées) détenait 269.166 droits de vote, représentant 0,27 % du nombre total des actions émises par Nyxoah au 10 juin 2026 (99.926.284), et 2.551.461 instruments financiers assimilés, représentant 2,55 % du nombre total des actions émises par Nyxoah au 10 juin 2026 (99.926.284).

La notification datée du 15 juin 2026 contient les informations suivantes :

Motif de la notification :
- Franchissement vers le bas du seuil minimum
- Acquisition ou cession de titres conférant le droit de vote ou de droits de vote
- Acquisition ou cession d'instruments financiers assimilés
Notification par : une entreprise mère ou une personne détenant le contrôle
Personnes tenues à la notification :
- Bank of America Corporation (avec adresse à 1209 Orange Street – Corporation Trust Center, Wilmington DE 19801, États-Unis)
Date du dépassement de seuil : le 11 juin 2026
Seuil franchi : 3 %
Dénominateur : 99.926.284
Détails de la notification :

A) Droits de vote	Notification précédente	Après la transaction
	# droits de vote	# droits de vote		% de droits de vote
Détenteurs de droits de vote		Attachés à des titres	Non liés à des titres	Attachés à des titres	Non liés à des titres
Bank of America Corporation	0	0		0,00 %
Bank of America, National Association	7.319	7.319		0,01 %
BofA Securities, Inc.	393.157	216.277		0,22 %
Merrill Lynch International	48.812	45.570		0,05 %
Sous-total	449.288	269.166		0,27 %
	TOTAL	269.166	0	0,27 %	0,00 %

B) Instruments financiers assimilés	Après la transaction
Détenteurs d’instruments financiers assimilés	Type d’instrument financier	Date d’échéance	Date ou délai d’exercice ou de conversion	# droits de vote pouvant être acquis en cas d’exercice de l’instrument	% de droits de vote	Règlement
Merrill Lynch International	Right to recall			15.000	0,02 %	physique
BofA Securities, Inc.	Rights of use			1.445.424	1,45 %	physique
BofA Securities, Inc.	Right to recall			1.088.536	1,09 %	physique
Bank of America, NA	Swap	15/10/2027		991	0,00 %	en espèces
Merrill Lynch International	Swap	15/02/2028		519	0,00 %	en espèces
Merrill Lynch International	Swap	15/10/2027		991	0,00 %	en espèces
	TOTAL			2.551.461	2,55 %

	TOTAL (A & B)			# droits de vote	% de droits de vote
				2.820.627	2,82 %

Chaine des entreprises contrôlées par l'intermédiaire desquelles la participation est effectivement détenue : Bank of America, National Association, BofA Securities, Inc. et Merrill Lynch International sont contrôlées par Bank of America Corporation. Bank of America Corporation n'est pas une entité contrôlée.

* *

Contact :
Nyxoah
John Landry, CFO
[email protected]

Pièce jointe

2026 06 17 PR Transparency notification (Robelga BAD21 Cochlear Gilde BofA) (FR)

GLOBENEWSWIRE (Distribution ID 1001188347)

Nyxoah Receives $15 Million from the European Investment Bank

Nyxoah Receives $15 Million from the European Investment Bank

Non-dilutive debt funding complements the Company’s June equity raise, bringing total capital raised to $110 million

Mont-Saint-Guibert, Belgium – June 17, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA), today announced that it has received $15 million (€13.8 million) in proceeds from the second tranche of its loan facility with the European Investment Bank (EIB). The drawdown follows the recent confirmation that the Company had satisfied the predefined criteria required to access this tranche.

With this drawdown, Nyxoah has raised approximately $110 million in total new capital in June 2026, combining the proceeds of its underwritten public offering with this non-dilutive EIB financing.

The EIB proceeds are intended first and foremost to accelerate the commercial launch of Genio in the United States, while also supporting continued investment in research and development and the scale-up of manufacturing. As non-dilutive capital, the EIB financing reinforces the Company’s balance sheet without diluting existing shareholders.

“Receiving these funds from the European Investment Bank completes a transformative financing for Nyxoah,” said Olivier Taelman, Chief Executive Officer. “The EIB’s continued support is a strong endorsement of our technology and of the long-term potential of our mission to make sleep simple for OSA patients. This non-dilutive capital, alongside the equity proceeds raised this month, allows us to accelerate the commercial launch of Genio in the United States while continuing to invest in innovation. We are entering the next phase of our growth from a position of strength.”

About Nyxoah

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study and receipt of approval from the FDA for a subset of adult patients with moderate to severe OSA with an AHI of greater than or equal to 15 and less than or equal to 65.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. FDA approved in August 2025 as prescription-only device.

Forward-looking statements

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or management’s current expectations regarding the intended use of the proceeds under the second tranche of the European Investment Bank loan; the Company’s capital position; the Genio system; the potential advantages of the Genio system; and the Company’s commercialization strategy and growth in the U.S. market. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. These risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on March 26, 2026 and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:

Nyxoah

John Landry, CFO

[email protected]

Rémi Renard, Head of Investor Relations & Corporate Communication

[email protected]

Attachment

ENGLISH_EIB Proceeds Received PR_DRAFT

GLOBENEWSWIRE (Distribution ID 1001188313)

Nyxoah Reçoit 15 Millions de Dollars de la Banque Européenne d’Investissement

Nyxoah Reçoit 15 Millions de Dollars de la Banque Européenne d’Investissement

Ce financement par dette non dilutif complète l’augmentation de capital de la Société réalisée en juin, portant le montant total des fonds levés à 110 millions de dollars

Mont-Saint-Guibert, Belgique – 17 juin 2026, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale dédiée au développement de solutions innovantes pour traiter l’apnée obstructive du sommeil (AOS), a annoncé aujourd’hui avoir reçu 15 millions de dollars (13,8 millions d’euros) de produits au titre de la deuxième tranche de sa facilité de prêt auprès de la Banque européenne d’investissement (BEI). Cette seconde tranche fait suite à la confirmation récente que la Société avait satisfait aux critères prédéfinis requis pour accéder à cette tranche.

Avec cette seconde tranche, Nyxoah a levé au total environ 110 millions de dollars de nouveaux capitaux en juin 2026, combinant les produits de son offre publique souscrite avec ce financement non dilutif de la BEI.

Les produits de la BEI sont destinés en premier lieu à accélérer le lancement commercial de Genio aux États-Unis, tout en soutenant la poursuite des investissements en recherche et développement et la montée en puissance de la production. En tant que capitaux non dilutifs, le financement de la BEI renforce le bilan de la Société sans diluer les actionnaires existants.

“La réception de ces fonds de la Banque Européenne d’Investissement vient parachever un financement transformateur pour Nyxoah”, a déclaré Olivier Taelman, Chief Executive Officer de Nyxoah. “Le soutien constant de la BEI constitue une marque de confiance forte envers notre technologie et le potentiel à long terme de notre mission, qui est de rendre le sommeil simple pour les patients souffrant d’AOS. Ces capitaux non dilutifs, conjugués aux produits de l’augmentation de capital levés ce mois-ci, nous permettent d’accélérer le lancement commercial de Genio aux États-Unis tout en continuant d’investir dans l’innovation. Nous abordons la prochaine phase de notre croissance en position de force.”

À propos de Nyxoah

Nyxoah opère dans le secteur des technologies médicales. Elle se concentre sur le développement et la commercialisation de solutions innovantes destinées à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS). La principale solution de Nyxoah est le système Genio®, une thérapie de neurostimulation du nerf hypoglosse sans sonde et sans batterie qui a reçu le marquage CE, centrée sur le patient et destinée à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS), le trouble respiratoire du sommeil le plus courant au monde. Ce dernier est associé à un risque accru de mortalité et des comorbidités, dont les maladies cardiovasculaires. La vision de Nyxoah est que les patients souffrant de SAOS doivent pouvoir profiter de nuits réparatrices et vivre pleinement leur vie.

À la suite de la finalisation probante de l’étude BLAST OSA, le système Genio® a reçu le marquage européen CE en 2019. Nyxoah a réalisé avec succès deux IPO : l’une sur Euronext Bruxelles en septembre 2020 et l’autre sur le NASDAQ en juillet 2021. Grâce aux résultats positifs de l’étude BETTER SLEEP, Nyxoah a reçu le marquage CE pour l’extension de ses indications thérapeutiques aux patients souffrant de collapsus concentrique complet (CCC), pour lesquels les thérapies concurrentes sont actuellement contre-indiquées. En outre, la Société a annoncé les résultats positifs de l’étude pivot DREAM IDE et l’obtention de l’autorisation de la FDA pour un sous-groupe de patients adultes atteints d’AOS modérée à sévère avec un IAH supérieur ou égal à 15 et inférieur ou égal à 65.

Pour plus d’informations, visitez www.nyxoah.com.

Attention – Marquage CE depuis 2019. Approuvé par la FDA en août 2025 en tant que dispositif disponible uniquement sur prescription médicale.

DÉCLARATIONS PROSPECTIVES

Certaines déclarations, convictions et opinions contenues dans le présent communiqué de presse sont de nature prospective et reflètent les attentes actuelles de la Société ou, le cas échéant, de ses administrateurs ou de sa direction concernant l’utilisation prévue des produits de la deuxième tranche du prêt de la Banque européenne d’investissement ; la situation financière de la Société ; le système Genio ; les avantages potentiels du système Genio ; ainsi que la stratégie de commercialisation et la croissance de la Société sur le marché américain. De par leur nature, les déclarations prospectives comportent un certain nombre de risques, d’incertitudes, d’hypothèses et d’autres facteurs susceptibles d’entraîner une différence significative entre les résultats ou événements réels et ceux exprimés ou sous-entendus dans les déclarations prospectives. Ces risques, incertitudes, hypothèses et facteurs pourraient avoir un impact négatif sur l’issue et les conséquences financières des projets et événements décrits dans le présent document. Ces risques et incertitudes comprennent, sans s’y limiter, les risques et incertitudes exposés dans la section « Facteurs de risque » du rapport annuel de la Société sur le formulaire 20-F pour l’exercice clos le 31 décembre 2025, déposé auprès de la Securities and Exchange Commission (« SEC ») le 26 mars 2026, ainsi que dans les rapports ultérieurs que la Société dépose auprès de la SEC. Une multitude de facteurs, y compris, sans s’y limiter, les changements dans la demande, la concurrence et la technologie, peuvent entraîner des événements, des performances ou des résultats réels sensiblement différents de toute évolution prévue. Les déclarations prospectives contenues dans le présent communiqué de presse concernant des tendances ou des activités passées ne constituent pas des garanties de performances futures et ne doivent pas être interprétées comme une assurance que ces tendances ou activités se poursuivront à l’avenir. En outre, même si les résultats ou les développements réels correspondent aux déclarations prospectives contenues dans le présent communiqué de presse, ces résultats ou développements ne sont pas nécessairement indicatifs des résultats ou développements à venir. Aucune déclaration ni garantie n’est faite quant à l’exactitude ou à l’équité de ces déclarations prospectives. En conséquence, la Société décline expressément toute obligation ou engagement de publier des mises à jour ou des révisions des déclarations prospectives contenues dans le présent communiqué de presse à la suite d’un changement dans les attentes ou d’un changement dans les événements, conditions, hypothèses ou circonstances sur lesquels ces déclarations prospectives sont fondées, sauf si la loi ou la réglementation l’exige expressément. Ni la Société, ni ses conseillers ou représentants, ni aucune de ses filiales, ni les dirigeants ou employés de ces entités ne garantissent que les hypothèses sous-jacentes à ces déclarations prospectives sont exemptes d’erreurs, et n’acceptent aucune responsabilité quant à l’exactitude future des déclarations prospectives contenues dans le présent communiqué de presse ou à la réalisation effective des développements prévus. Vous ne devez pas vous fier indûment aux déclarations prospectives, qui ne sont valables qu’à la date du présent communiqué de presse.

Contacts :

Nyxoah

John Landry, CFO

[email protected]

Rémi Renard, Head of Investor Relations & Corporate Communication

[email protected]

Pièce jointe

FRENCH_EIB Proceeds Received PR_DRAFT

GLOBENEWSWIRE (Distribution ID 1001188313)

Bitget s’associe à Paydify pour étendre les paiements en stablecoins aux commerçants du monde entier

VICTORIA, Seychelles, 17 juin 2026 (GLOBE NEWSWIRE) — Bitget, la plus grande bourse universelle au monde, a annoncé aujourd’hui la conclusion d’un partenariat stratégique avec Paydify, une plateforme de paiement offrant des transactions fluides en stablecoins entre utilisateurs et commerçants, ce qui permettra aux commerces du monde entier d’accepter les paiements en stablecoins. Ce partenariat offre aux commerçants connectés à Paydify un accès à la base d’utilisateurs internationale de Bitget via une seule et même solution de paiement intégrée, simplifiant ainsi les processus d’acceptation des paiements en stablecoins au sein de l’écosystème Web3 en pleine expansion.

Les stablecoins font désormais partie des cryptoactifs les plus pratiques en termes de fonctionnalités de paiement, offrant un règlement plus rapide, des transactions sans frontières, une disponibilité 24 heures sur 24, 7 jours sur 7 et une diminution des problèmes de paiement. D’après les données d’Andreessen Horowitz, le volume des transactions consumer-to-business (C2B) en stablecoins a augmenté de 128 % sur douze mois, soit plus du double sur cette période, ce qui illustre à quel point les stablecoins sont au coeur des paiements quotidiens.

Cependant, l’adhésion des commerçants a rencontré un succès limité en raison de la fragmentation des liquidités et de l’instabilité des réseaux de paiement. Le partenariat entre Bitget et Paydify vient remédier à ce problème en améliorant la connectivité entre les plateformes d’échange, les commerçants, les portefeuilles et les utilisateurs finaux. L’infrastructure de Paydify propose une passerelle unique pour les paiements en stablecoins, permettant ainsi aux entreprises de simplifier l’aspect technique tout en garantissant une expérience de paiement fluide.

« L’UEX de Bitget est conçue pour rendre les actifs numériques plus accessibles, plus intuitifs et plus ancrés dans la réalité », a déclaré Gracy Chen, PDG de Bitget. « Notre partenariat avec Paydify vise à étendre cette stratégie aux paiements en stablecoins en offrant aux commerçants une infrastructure plus simple et plus efficace qui leur permet d’accéder aux 125 millions d’utilisateurs de Bitget à travers le monde. »

Paydify accepte les paiements en stablecoins sur les principaux portefeuilles et réseaux blockchain. Les commerçants peuvent ainsi traiter des paiements sur la blockchain avec peu d’exigences d’intégration tout en conservant le contrôle de leurs fonds.

« L’avenir des solutions de paiements ne se limite pas à un simple transfert d’argent de portefeuille à portefeuille. L’enjeu est plutôt de permettre à des millions d’utilisateurs de cryptomonnaies de dépenser leurs actifs numériques facilement et depuis n’importe où. Notre association avec Bitget permet de faire évoluer les stablecoins du statut d’actifs d’investissement à celui de moyen de paiement », a déclaré Sean Dong, directeur principal des opérations commerciales chez Paydify.

Ce partenariat renforce le modèle UEX de Bitget en intégrant les fonctionnalités de trading, de détention d’actifs et d’achat au sein d’un seul et même environnement unique. Grâce à l’association de ces services, les actifs numériques s’imposent comme un moyen de paiement classique et l’écosystème dépasse le cadre du trading traditionnel pour s’orienter vers des solutions de paiement pratiques et quotidiennes.

À propos de Paydify

Paydify est une infrastructure technologique de paiement qui permet de réaliser des transactions en toute simplicité en stablecoins directement entre commerçants et utilisateurs. Conçu pour l’écosystème Web3 et les entreprises natives du numérique, Paydify accepte les paiements rapides sur les principaux portefeuilles et réseaux blockchain, permettant ainsi aux commerçants de recevoir instantanément des stablecoins provenant de millions d’utilisateurs de cryptoactifs, avec une intégration minimale et un contrôle total, sans intermédiaires ni dépositaire de fonds.

Pour en savoir plus sur Paydify, consultez le site paydify.com.

À propos de Bitget

Bitget est la première bourse universelle (UEX) du monde. Au service de plus de 125 millions d’utilisateurs, elle donne accès à plus de 2 millions de jetons crypto et à plus de 100 actions tokenisées, ETF, matières premières, devises et métaux précieux comme l’or. Son écosystème s’engage à aider les utilisateurs à négocier plus intelligemment en s’appuyant sur un agent IA qui accompagne l’exécution des transactions. Bitget entend promouvoir l’adoption des cryptomonnaies grâce à des partenariats stratégiques conclus avec LALIGA et MotoGP™. Pour faire écho à sa stratégie d’impact mondial, Bitget s’est associée à l’UNICEF pour appuyer l’éducation à la blockchain auprès de 1,1 million de personnes d’ici à 2027. Actuellement leader du marché de la finance traditionnelle tokenisée, Bitget propose les frais les plus bas et la liquidité la plus élevée du secteur dans plus de 150 régions à travers le monde.

Pour tout complément d’information, veuillez visiter : Site Internet | X | Telegram | LinkedIn | Discord

Pour toute demande média, veuillez nous contacter à l’adresse suivante : [email protected]

Mise en garde sur les risques : les cours des actifs numériques peuvent fluctuer et connaître une forte volatilité. Il est conseillé aux investisseurs de n’engager que les fonds qu’ils peuvent se permettre de perdre. La valeur de votre investissement peut être affectée et il est possible que vous n’atteigniez pas vos objectifs financiers ou que vous ne parveniez pas à récupérer votre investissement principal. Il est toujours recommandé de solliciter l’avis d’un spécialiste financier indépendant et de tenir compte de votre expérience ainsi que de votre situation financière personnelle. Les performances passées ne préjugent pas des résultats futurs. Bitget décline toute responsabilité en cas de pertes potentielles. Aucune des informations contenues dans le présent document ne constitue un conseil financier. Pour plus d’informations, veuillez consulter nos Conditions d’utilisation.

Une photo annexée au présent communiqué est disponible à l’adresse suivante : http://www.globenewswire.com/NewsRoom/AttachmentNg/c2192a03-423d-4237-949d-82fe0f281eeb

GLOBENEWSWIRE (Distribution ID 1001188272)

Smartbird Appoints New CEO to Advance AI Infrastructure Strategy

Nadia Carlsten, AI and advanced computing industry leader, appointed president,
CEO and board member

Independent Director Lily Yan Hughes appointed as board chair

Allbirds, Inc. name changed to Smartbird, Inc.

SAN FRANCISCO, June 17, 2026 (GLOBE NEWSWIRE) — Smartbird, Inc. (NASDAQ: BIRD), an AI infrastructure provider, today announced the appointment of Nadia Carlsten as president and chief executive officer. Carlsten has also joined Smartbird’s board of directors.

The company has completed its previously announced definitive agreement to sell the Allbirds brand and footwear assets. With the transition to Smartbird now completed, the company also strengthened its balance sheet by increasing the size of its convertible financing facility from $50 million to $100 million. The expanded capital base provides Smartbird with additional resources to execute its AI infrastructure strategy.

A visionary and builder, Carlsten brings decades of deep technical expertise in AI compute infrastructure combined with commercial execution across platform scaling, go-to-market, partnerships and capital strategy. She has served as a trusted partner to boards and investors, with a strong track record of building high-performing teams, stewarding capital and generating strong returns on investment.

While serving as CEO of DCAI, an AI company delivering large-scale GPU compute infrastructure and enterprise AI, Carlsten launched a sovereign AI supercomputer in partnership with NVIDIA. As vice president of product at Google spin-off SandboxAQ, Carlsten led the product portfolio across AI, security and hardware platforms. She has also done extensive work on advanced computing platforms, including launching Amazon’s quantum computing service during her tenure at Amazon Web Services.

Carlsten actively contributes to global technology discourse, advising on strategy, investment decisions and scaling of AI and digital platforms. As a member of the World Economic Forum’s Global Future Council on Next Generation Computing, Carlsten advises on the strategic implications of advanced computing and AI infrastructure.

Carlsten holds bachelor degrees in chemistry and physics from the University of Virginia, and a doctorate in engineering from the University of California, Berkeley.

Carlsten replaces Joe Vernachio, who is resigning from the company and the board of directors. Annie Mitchell will continue to serve as chief financial officer, a position she has held for the past three years. Lily Yan Hughes, who has served as an independent director of the company since October 2025, has been appointed board chair. Hughes has extensive technology experience and a 30-year track record of operational excellence across corporate governance, capital markets and corporate finance.

“We are thrilled to usher in this new era of the company with Nadia at the helm. Her groundbreaking work and visionary mindset will be instrumental in establishing a foothold in the market and building a scalable long-term solution for enterprise customers,” said Hughes. “The board selected Nadia because of the breadth of her experience and demonstrated success delivering breakthrough ideas and initiatives at scale. The pairing of her vision and expertise with Annie's continued financial leadership make us confident in the trajectory of the business and our ability to build long-term shareholder value.”

The rise of AI development and adoption has created unprecedented structural demand for specialized, high-performance compute. The AI infrastructure market is entering a new phase as enterprises move from experimentation to production-scale deployment, creating demand for dedicated infrastructure that is more flexible and cost-efficient than traditional hyperscale cloud offerings. Smartbird delivers dedicated AI infrastructure as a managed service, providing the performance, control, and scalability of ownership without the capital investment and operational complexity. The company is in active discussions with prospective customers across its target verticals and is currently designing its first cluster deployments.

“Smartbird is entering the market at a pivotal moment in the evolution of AI infrastructure,” said Dr. Carlsten, CEO of Smartbird. “AI is rapidly becoming mission-critical for organizations across every industry, yet many organizations lack a practical path to deploy and operate the dedicated infrastructure these workloads require.

There is a clear opportunity to meet the growing need for enterprise-grade AI infrastructure that delivers control and performance without the capital and operational burden of hardware ownership. With a differentiated strategy, significant capital, and the opportunity to build an exceptional team, we are uniquely positioned to capitalize on one of the most significant infrastructure opportunities of the next decade.”

About Smartbird, Inc.
Smartbird delivers dedicated AI infrastructure as a service, giving organizations the performance, control, and security of a private AI cluster without requiring them to finance, operate, or maintain the underlying infrastructure. Smartbird manages the entire lifecycle, from procurement and deployment to operations and hardware refreshes, so customers can focus on AI workloads, not AI infrastructure.

Stock Information
Effective today, Allbirds, Inc. has changed its name to Smartbird, Inc. The company’s Class A common stock listed on the Nasdaq Global Select Market will continue to trade under the ticker symbol “BIRD” and its CUSIP number remains unchanged.

Inducement Grant
The company has approved, as a material inducement to Dr. Carlsten entering into employment with the company, a restricted stock unit award (“RSU Award”) that is intended to qualify as an “inducement grant” in accordance with Nasdaq Listing Rule 5635(c)(4). The RSU Award is comprised of 1,532,379 RSUs converting into an equal number of shares of the Class A common stock, with 255,397 shares vesting immediately and the remaining shares vesting in 16 equal quarterly installments.

Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on management's current beliefs, assumptions, and information, and include statements other than historical facts—such as statements regarding future financial performance, profitability, cost savings, business strategy, and objectives of management. Forward-looking statements can often be identified by words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “target,” “will,” or similar expressions. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including: our ability to execute our new business strategy and achieve financial targets; future results of operations, financial condition, business strategy and plans; unfavorable economic conditions; and our ability to obtain additional capital. A further discussion of these and other factors that could cause financial results, performance, and achievements to differ materially from any results, performance, or achievements anticipated, expressed, or implied by these forward-looking statements is included in the filings we make with the SEC, including our most recent annual report on Form 10-K and quarterly report on Form 10-Q and other reports we may file with the SEC from time to time. These forward-looking statements speak only as of the date of this press release, and we undertake no obligation to update them except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in or expressed by, and you should not place undue reliance on our forward-looking statements.

Investor Contact:

[email protected]

Media Contact:

[email protected]

GLOBENEWSWIRE (Distribution ID 9748379)

Univar Solutions Expands Exclusive Beauty, Personal Care, and Pharmaceutical Ingredients Partnership with American Distilling in EMEA

ROTTERDAM, The Netherlands, June 17, 2026 (GLOBE NEWSWIRE) — Univar Solutions B.V., a subsidiary of Univar Solutions LLC (“Univar Solutions” or “the Company”), a leading global solutions provider to users of specialty ingredients and chemicals, today announced an expanded distribution partnership with American Distilling through its Ingredients + Specialties from Univar Solutions division. Under the new agreement, Univar Solutions will distribute American Distilling’s portfolio of high-quality, natural specialty ingredients. The agreement includes traditional witch hazel (alcohol-free options and customizable grades) for personal care, cosmetic, and pharmaceutical applications across select European, Middle Eastern, and African (EMEA) markets*.

“Partnering with American Distilling in EMEA helps position us as a leading and trusted distributor for this product range while strengthening our botanical extract offering,” said Nick Powell, CEO of Ingredients + Specialties from Univar Solutions. “We’ve long supported these specialty ingredients in North America, and with a robust supply chain and experienced technical teams now available regionally, we’re able to offer local stock and faster supply availability to customers.”

Witch hazel is a multifunctional botanical extract used in facial care, cleansers, body washes, hair care, eye gels, and personal hygiene products. Native to the woodlands of the Northeastern United States, this Hamamelis-derived ingredient offers natural astringent, anti-inflammatory, antioxidant, and antimicrobial benefits. As a gentle, plant-based alternative to synthetic astringents, it supports a broad range of applications, from toners and moisturizers to pads, ointments, creams, sprays, and therapeutic formulations, enhancing both natural content and overall product performance.

“This partnership represents an important step in bringing high-quality United States Pharmacopeia (USP) witch hazel products to customers across the EMEA region,” said Bryan Jackowitz, vice president of American Distilling, Inc. “By collaborating with Univar Solutions, we are now able to market our full portfolio of cosmetic and pharmaceutical witch hazel extracts, giving customers greater flexibility to identify the solution that best fits their specific application needs, with a robust distribution infrastructure to help strengthens their supply chains. We are excited about the long-term potential of this collaboration and look forward to growing together.”

With the addition of this portfolio, Univar Solutions further solidifies its position as a leading distributor of high-performance ingredients for brands shaping the next generation of beauty, personal care, and pharmaceutical products. Customers benefit from the Company’s comprehensive formulation support, advanced laboratory capabilities, deep market insights, and robust distribution network. The Company also offers access to its global Solution Center in Essen, Germany, providing regional support for product development and scale-up.

Learn more about Ingredients + Specialties from Univar Solutions’ portfolio and technical capabilities.

*Markets in agreement include: Albania, Algeria, Austria, Belgium, Bosnia, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Herzegovina, Hungary, Germany, Greece, Ireland,, Italy, Latvia, Lithuania, Luxembourg, Macedonia, Moldovia, Monaco, Morrocco, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, the Netherlands, Tunisia, Turkey, Ukraine, and United Kingdom.

About Univar Solutions
Univar Solutions is a leading global specialty chemical and ingredient distributor representing a premier portfolio from the world's leading producers. With one of the industry's largest private transportation fleets and technical sales force, unparalleled logistics know-how, deep market and regulatory knowledge, formulation and recipe development, and leading digital tools, the Company is well-positioned to offer tailored solutions and value-added services to a wide range of markets, industries, and applications. While fulfilling its purpose to help keep communities healthy, fed, clean, and safe, Univar Solutions is committed to helping customers and suppliers innovate and focus on Growing Together. Learn more at univarsolutions.com.

About Ingredients + Specialties from Univar Solutions
Ingredients + Specialties from Univar Solutions brings the best products, people, and results to specialty customers and suppliers seeking to power modern life. By combining science, innovation, and deep expertise with a leading specialty portfolio, we help find the solutions needed to safely improve lives and communities across the globe. Learn more at univarsolutions.com.

About American Distilling
American Distilling is committed to maintaining our position as the industry leader, supplying the health and beauty care and pharmaceutical industries with the highest quality, sustainable distilled Witch Hazel ingredient products. Their talented staff of professionals is dedicated to providing the highest standards of customer service, personal integrity, and consumer value. Each day, they demonstrate their expertise by producing “excellence assured” ingredients for formulations and assisting with new product development to form long-term partnerships with their valued customers. Learn more at americandistilling.com.

Forward-Looking Statements and Information
This communication contains “forward-looking statements” under applicable law regarding financial and operating items relating to the Company's business. Forward-looking statements generally can be identified by words such as “believes,” “expects,” “may,” “will,” “should,” “could,” “seeks,” “intends,” “plans,” “estimates,” “anticipates” or other comparable terms. All forward-looking statements made in this communication are qualified by this cautionary language.

Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company's control, that could result in expectations not being realized or could otherwise materially and adversely affect the Company's business, financial condition, results of operations or cash flows. Although the forward-looking statements are based on what management believes to be reasonable assumptions, we caution you that the forward-looking information presented in this communication is not a guarantee of future events or results, and that actual events or results may differ materially from those made in or suggested by the forward-looking information contained in this communication. For additional information regarding factors that could affect the Company, please see the Company's most recent annual report and other financial reports, including the information set forth under the caption “Risk Factors.” Any forward-looking statements represent the Company's views only as of the date of this communication and should not be relied upon as representing the Company's views as of any subsequent date, and the Company undertakes no obligation, other than as may be required by law, to update any forward-looking statement.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/1a0f125e-9860-41fc-bd5d-3e4b878928a1

https://www.globenewswire.com/NewsRoom/AttachmentNg/c253a85c-ac7c-4f0e-9eac-36644f8af1e8

GLOBENEWSWIRE (Distribution ID 9748380)